Pfizer

  • Xalkori 2017 report

    Xalkori 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Xeljanz 2017 report

    Xeljanz 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Xtandi 2017 report

    Xtandi 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Xyntha Solofuse 2017 report

    Xyntha Solofuse 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 26 Pages The 5 Key Questions Addressed by this...

  • BeneFix 2016 report

    BeneFix 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Bosulif 2016 report

    Bosulif 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Chantix 2016 report

    Chantix 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 19 Pages The 5 Key Questions Addressed by this Report:...

  • Duavee 2016 report

    Duavee 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Dyloject 2016 report

    Dyloject 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Elelyso 2016 report

    Elelyso 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 32 Pages The 5 Key Questions Addressed by this Report:...

  • Eliquis 2016 report

    Eliquis 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Embeda 2016 report

    Embeda 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 30 Pages The 5 Key Questions Addressed by this Report:...